Kotak Neo says US PERM suspension won’t hit Indian IT revenues

Kotak Neo’s Shrikant Chouhan said the US administration’s suspension of PERM processing for major Indian tech firms won’t have immediate impact on corporate revenues, and cited a limited pharma trade margin cap to 7%.